Showing results (61-70 of 1,602) with videos related to
Sort By:
Pageof 161
American Heart Journal|October 31, 2006
Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohortsPaul A Heidenreich, Gregg C FonarowCurrent Heart Failure Reports|July 23, 2005
Quality of care and outcomes in acute decompensated heart failure: The ADHERE RegistryClyde W Yancy, Gregg C Fonarow, Seminars in Dialysis|November 10, 2007
Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDSTamara B Horwich, Gregg C FonarowJACC. Heart Failure|August 5, 2026
National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection FractionMohammad Keykhaei, Alexander T Sandhu, Priscilla Y Hsue, et al.Critical Pathways in Cardiology|March 15, 2008
In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management ProgramGregg C Fonarow, Anna Gawlinski, Karol WatsonCardiology Research and Practice|May 12, 2011
Recent US Patterns and Predictors of Prevalent Diabetes among Acute Myocardial Infarction PatientsBruce Ovbiagele, Daniela Markovic, Gregg C FonarowJACC. Heart Failure|March 14, 2014
Drug therapy to reduce early readmission risk in heart failure: ready for prime time?Muthiah Vaduganathan, Gregg C Fonarow, Mihai GheorghiadeJournal of Cardiac Failure|May 8, 2021
Palliative Care Services in Patients Admitted With Cardiogenic Shock in the United States: Frequency and Predictors of 30-Day ReadmissionZekun Feng, Gregg C Fonarow, Boback ZiaeianHeart Failure Clinics|October 10, 2022
SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical BenefitsNeal M Dixit, Boback Ziaeian, Gregg C FonarowCardiac Failure Review|December 24, 2021
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection FractionNicholas K Brownell, Boback Ziaeian, Gregg C FonarowPageof 161